Research programme: rheumatoid arthritis antibody therapies - Yuhan
Alternative Names: Anti-RA - Yuhan; Humanised therapeutic antibody - YuhanLatest Information Update: 16 Jul 2016
At a glance
- Originator Yuhan
- Class Antibodies; Monoclonal antibodies
- Mechanism of Action Tumour necrosis factor alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Rheumatoid-arthritis in South Korea (Parenteral)